Digestive Diseases

Using GLP-1 Receptor Agonists in Patients with Inflammatory Bowel Disease: A Systematic Review and Single-Arm Meta-Analysis

By Omar Khasawneh, Kyrillos Mahrous Gerges, Islam Khasawneh, Muhammed Elhadi

Meta-analysisInterventions

Declared no competing interests

The paper

Omar Khasawneh, Kyrillos Mahrous Gerges, Islam Khasawneh, Muhammed Elhadi

Jordan University of Science and Technology; Korea University

Digestive Diseases, 18 Aug 2026

doi.org/10.1159/000553479 PubMed 42611799

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Neurology Genetics4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression